Potentiation of [DELTA]F508- and G551D-CFTR-Mediated Cl.sup.- Current by Novel Hydroxypyrazolines
The most common mutation of CFTR, affecting approximately 90% of CF patients, is a deletion of phenylalanine at position 508 (F508del, [DELTA]F508). Misfolding of [DELTA]F508-CFTR impairs both its trafficking to the plasma membrane and its chloride channel activity. To identify small molecules that...
Saved in:
Published in | PloS one Vol. 11; no. 2 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Public Library of Science
10.02.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!